Assyro AI

Orange Book product · Brand (NDA)

BELSOMRA

SUVOREXANT

Brand (NDA)NDA 204569RX MERCK SHARP DOHME

At a glance

Aug 13, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 13, 2014

    12 yr ago

  2. Today

  3. Patent 7951797 expires

    Listed drug substance patent expiration.

    Nov 20, 2029

    in 3 yr 6 mo

  4. Patent 10098892 expires

    Listed drug product patent expiration.

    May 29, 2033

    in 7 yr 1 mo

  5. Patent 11980623 expires

    Listed drug product patent expiration.

    May 29, 2033

    in 7 yr 1 mo

Pharmaceutical detail

Active ingredient

SUVOREXANT

Strength

5MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 204569

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7951797Nov 20, 2029in 3 yr 6 mo
SubstanceProductU-620
10098892May 29, 2033in 7 yr 1 mo
Product
11980623May 29, 2033in 7 yr 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.